Overseed
Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, proximity of collaborations and certified quality of cultivated products, in direct connection with medical and scientific studies. Patient-driven, the culture of Overseed is based on people, product quality and value creation.
Overseed
A French biotech company mastering the production of therapeutic cannabis, providing high-quality products for laboratories, patients, and the healthcare industry.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Advanced extraction equipment for full-spectrum extracts.
Purification technologies for active pharmaceutical ingredients.
Analytical instruments for cannabinoid characterization.
Stability testing equipment for product stabilization.
Service Requirements
Co-R&D services for cannabinoid-based product development.
Consulting on GMP certification for production facilities.
Training on advanced cannabis cultivation techniques.
Expertise in navigating regulatory compliance within the cannabis industry.
Infrastructure Requirements
GMP-certified production facilities.
High-security storage for cannabis products.
Environmental control systems for cannabis cultivation.
Scalable extraction and purification infrastructure.
Talent Requirements
Experts in cannabis genetics and agronomy.
Pharmaceutical chemists specializing in cannabinoids.
Regulatory compliance specialists for the cannabis industry.
Experienced R&D scientists in cannabinoid production and stabilization.
AI Insights
Growth Trajectory
The company's growth potential is indicated by its focus on expanding production and research in cannabinoid-based medical applications, combined with a commitment to meeting patient and healthcare industry needs.
Market Opportunity
The company's strongest market advantage lies in being the first French actor with R&D authorization for medical cannabis cultivation, positioning them to capitalize on the growing therapeutic cannabis market.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats